Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph B

Showing results (31-40 of 862) with videos related to

Pageof 87
Sort By:
The New England Journal of Medicine|May 31, 2018
Multiplicity Considerations in Clinical TrialsAlex Dmitrienko, Ralph B D'Agostino
JEMS : a Journal of Emergency Medical Services|May 26, 2007
Kids in need: immediate psychological support for children after a disasterMilan Nadkarni, Ralph B Leonard
Current Protocols in Protein Science|April 23, 2008
Preparation and application of polyclonal and monoclonal sequence-specific anti-phosphoamino acid antibodiesTong Sun, Ralph B Arlinghaus
The New England Journal of Medicine|January 18, 2018
Noninferiority TrialsLaura Mauri, Ralph B D’Agostino
Journal of the Mississippi State Medical Association|September 11, 2010
Report card on tobacco use in Mississippi, 2009Deirdre B Rogers, Ralph B Vance
European Heart Journal|October 31, 2003
Global risk assessment for cardiovascular disease and astute clinical judgementCharles H Hennekens, Ralph B D'Agostino
JACC. Cardiovascular Imaging|August 31, 2020
Mid-Cancer Left Ventricular Function Measures Predict Long-Term Post-Cancer Left Ventricular Ejection FractionW Gregory Hundley, Ralph B D'Agostino
Archives of Internal Medicine|June 11, 2008
Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort--invited commentaryMichael J Pencina, Ralph B D'Agostino
American Journal of Epidemiology|July 21, 2012
Invited commentary: Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performanceRalph B D'Agostino, Michael J Pencina
Science Translational Medicine|April 28, 2012
Thoroughly modern risk prediction?Michael J Pencina, Ralph B D'Agostino
Pageof 87

Showing results (31-40 of 862) with videos related to

Sort By:
Pageof 87
The New England Journal of Medicine|May 31, 2018
Multiplicity Considerations in Clinical TrialsAlex Dmitrienko, Ralph B D'Agostino
JEMS : a Journal of Emergency Medical Services|May 26, 2007
Kids in need: immediate psychological support for children after a disasterMilan Nadkarni, Ralph B Leonard
Current Protocols in Protein Science|April 23, 2008
Preparation and application of polyclonal and monoclonal sequence-specific anti-phosphoamino acid antibodiesTong Sun, Ralph B Arlinghaus
The New England Journal of Medicine|January 18, 2018
Noninferiority TrialsLaura Mauri, Ralph B D’Agostino
Journal of the Mississippi State Medical Association|September 11, 2010
Report card on tobacco use in Mississippi, 2009Deirdre B Rogers, Ralph B Vance
European Heart Journal|October 31, 2003
Global risk assessment for cardiovascular disease and astute clinical judgementCharles H Hennekens, Ralph B D'Agostino
JACC. Cardiovascular Imaging|August 31, 2020
Mid-Cancer Left Ventricular Function Measures Predict Long-Term Post-Cancer Left Ventricular Ejection FractionW Gregory Hundley, Ralph B D'Agostino
Archives of Internal Medicine|June 11, 2008
Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort--invited commentaryMichael J Pencina, Ralph B D'Agostino
American Journal of Epidemiology|July 21, 2012
Invited commentary: Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performanceRalph B D'Agostino, Michael J Pencina
Science Translational Medicine|April 28, 2012
Thoroughly modern risk prediction?Michael J Pencina, Ralph B D'Agostino
Pageof 87